Trial Outcomes & Findings for Perianal Fistula (PAF) Validation and Burden of Illness Study (NCT NCT03981939)

NCT ID: NCT03981939

Last Updated: 2021-04-21

Results Overview

Index date first time participant meets case definition(diagnosis of CD with CPAF in index period).Participants divided as:2 diagnosis/imaging codes(IC),2 codes must be in 2 year(yr) period of each other;3 diagnosis/IC/intervention code/EUA+seton;3 diagnosis/IC/intervention code/EUA+seton,diagnosis/IC requirements are satisfied,codes must be in 2yr period of each other;2 diagnosis/IC;3 diagnosis/IC,3 codes must be in 2yr period of each other;3 diagnosis/IC;diagnosis/IC+(EUA+Seton);diagnosis/IC+(EUA+Seton),2 codes must be in 2yr period of each other;3 diagnosis /IC+intervention code 4 codes must be in 2 yr period of each other;2 IC/intervention code/diagnosis code/EUA+seton;2 IC/intervention code/diagnosis code/EUA+seton,IC requirements are satisfied, codes must be in 2yr period of each other;2 diagnosis/IC+intervention code;3 diagnosis/IC+intervention code;2 diagnosis/IC+intervention code,3 codes must be in 2yr period of each other;diagnosis/imaging/intervention codes;diagnosis/IC.

Recruitment status

COMPLETED

Target enrollment

3032 participants

Primary outcome timeframe

From the date of CD diagnosis up to the index date (approximately 5 years)

Results posted on

2021-04-21

Participant Flow

Data from participants were collected for this retrospective observational study at a single investigative site in Canada from 2 July 2019 to 31 December 2019.

Participants with a diagnosis of Crohn's disease (CD) with and without Complex Perianal Fistula (CPAF) were enrolled from The Ottawa Hospital (TOH) and Institute for Clinical Evaluative Sciences (ICES) database and were observed retrospectively in this study.

Participant milestones

Participant milestones
Measure
CD Participants With CPAF - The Ottawa Hospital (TOH)
Participants diagnosed with CPAF from TOH were observed retrospectively in this arm group for the index period (April 1, 2007 to March 31, 2013).
CD Participants Without CPAF (ICES Database)
Participants diagnosed with CD and without CPAF from ICES database who did not meet the case definition were observed retrospectively in this arm group for the index period (April 1, 2007 to March 31, 2013).
CD Participants With CPAF (ICES Database)
Participants with CD and CPAF from ICES database who met the case definition were observed retrospectively in this arm group for the index period (April 1, 2007 to March 31, 2013).
Overall Study
STARTED
549
1902
581
Overall Study
COMPLETED
549
1902
581
Overall Study
NOT COMPLETED
0
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
CD Participants With CPAF - TOH
n=549 Participants
Participants diagnosed with CPAF from TOH were observed retrospectively in this arm group for the index period (April 1, 2007 to March 31, 2013).
CD Participants Without CPAF (ICES Database)
n=1902 Participants
Participants diagnosed with CD and without CPAF from ICES database who did not meet the case definition were observed retrospectively in this arm group for the index period (April 1, 2007 to March 31, 2013).
CD Participants With CPAF (ICES Database)
n=581 Participants
Participants with CD and CPAF from ICES database who met the case definition were observed retrospectively in this arm group for the index period (April 1, 2007 to March 31, 2013).
Total
n=3032 Participants
Total of all reporting groups
Age, Continuous
38.12 years
n=549 Participants
31.83 years
n=1902 Participants
33.09 years
n=581 Participants
34.34 years
n=3032 Participants
Sex: Female, Male
Female
304 Participants
n=549 Participants
903 Participants
n=1902 Participants
279 Participants
n=581 Participants
1486 Participants
n=3032 Participants
Sex: Female, Male
Male
245 Participants
n=549 Participants
999 Participants
n=1902 Participants
302 Participants
n=581 Participants
1546 Participants
n=3032 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Region of Enrollment
Canada
549 Participants
n=549 Participants
1902 Participants
n=1902 Participants
581 Participants
n=581 Participants
3032 Participants
n=3032 Participants

PRIMARY outcome

Timeframe: From the date of CD diagnosis up to the index date (approximately 5 years)

Population: All participants identified from TOH with and without CPAF were included in the analysis. Participants could meet more than more case definition.

Index date first time participant meets case definition(diagnosis of CD with CPAF in index period).Participants divided as:2 diagnosis/imaging codes(IC),2 codes must be in 2 year(yr) period of each other;3 diagnosis/IC/intervention code/EUA+seton;3 diagnosis/IC/intervention code/EUA+seton,diagnosis/IC requirements are satisfied,codes must be in 2yr period of each other;2 diagnosis/IC;3 diagnosis/IC,3 codes must be in 2yr period of each other;3 diagnosis/IC;diagnosis/IC+(EUA+Seton);diagnosis/IC+(EUA+Seton),2 codes must be in 2yr period of each other;3 diagnosis /IC+intervention code 4 codes must be in 2 yr period of each other;2 IC/intervention code/diagnosis code/EUA+seton;2 IC/intervention code/diagnosis code/EUA+seton,IC requirements are satisfied, codes must be in 2yr period of each other;2 diagnosis/IC+intervention code;3 diagnosis/IC+intervention code;2 diagnosis/IC+intervention code,3 codes must be in 2yr period of each other;diagnosis/imaging/intervention codes;diagnosis/IC.

Outcome measures

Outcome measures
Measure
CD Participants With CPAF - TOH
n=549 Participants
Participants diagnosed with CPAF from TOH were observed retrospectively in this arm group for the index period (April 1, 2007 to March 31, 2013).
CD Participants With CPAF (ICES Database)
Participants with CD and CPAF from ICES database who met the case definition were observed retrospectively in this arm group for the index period (April 1, 2007 to March 31, 2013).
Advanced Intervention
Participants with CD and CPAF received 2 x EUA ± seton and single EUA ± seton, followed by an advanced intervention or diversion procedure. The participants who did not receive EUA ± seton received advanced intervention or diversion as their 1st line of treatment in this group and were observed retrospectively in this arm group for the index period (April 1, 2007 to March 31, 2013).
Objective 1: Number of CD Participants Who Have CPAF Using Various Codes in an TOH Database
Any 2 Diagnosis/IC, in a 2 Year Period of Each Other
120 Participants
Objective 1: Number of CD Participants Who Have CPAF Using Various Codes in an TOH Database
Any 3 Diagnosis/ IC/ Intervention Code/EUA+seton
120 Participants
Objective 1: Number of CD Participants Who Have CPAF Using Various Codes in an TOH Database
Any 3 Diagnosis/ IC/ Intervention/EUA+seton, Diagnosis/ IC Requirements are Satisfied
127 Participants
Objective 1: Number of CD Participants Who Have CPAF Using Various Codes in an TOH Database
Any 2 Diagnosis/ IC
127 Participants
Objective 1: Number of CD Participants Who Have CPAF Using Various Codes in an TOH Database
Any 3 Diagnosis/ IC, 3 Codes Must be in 2 Year Period of Each Other
88 Participants
Objective 1: Number of CD Participants Who Have CPAF Using Various Codes in an TOH Database
Any 3 Diagnosis/ IC
97 Participants
Objective 1: Number of CD Participants Who Have CPAF Using Various Codes in an TOH Database
Any Diagnosis/ IC + (EUA+ Seton)
83 Participants
Objective 1: Number of CD Participants Who Have CPAF Using Various Codes in an TOH Database
Any Diagnosis/ IC + (EUA+Seton), in a 2 Year Period of Each Other
78 Participants
Objective 1: Number of CD Participants Who Have CPAF Using Various Codes in an TOH Database
Any 3 Diagnosis/IC + Intervention Code, 4 Codes Must be in 2 Year Period of Each Other
66 Participants
Objective 1: Number of CD Participants Who Have CPAF Using Various Codes in an TOH Database
Any 2 IC Intervention Code/ Diagnosis Code/EUA+Seton
127 Participants
Objective 1: Number of CD Participants Who Have CPAF Using Various Codes in an TOH Database
Any 2 Imaging/Intervention/ Diagnosis Code/EUA+seton, If Imaging Code Requirements Are Satisfied
127 Participants
Objective 1: Number of CD Participants Who Have CPAF Using Various Codes in an TOH Database
Any 2 Diagnosis/ IC + Intervention Code
69 Participants
Objective 1: Number of CD Participants Who Have CPAF Using Various Codes in an TOH Database
Any 3 Diagnosis/ IC + an Intervention Code
67 Participants
Objective 1: Number of CD Participants Who Have CPAF Using Various Codes in an TOH Database
Any 2 Diagnosis/ IC + Intervention Code, 3 Codes Must be in 2 Year Period of Each Other
69 Participants
Objective 1: Number of CD Participants Who Have CPAF Using Various Codes in an TOH Database
Any Diagnosis/ IC / Intervention Codes
146 Participants
Objective 1: Number of CD Participants Who Have CPAF Using Various Codes in an TOH Database
Any Diagnosis/ IC
146 Participants

PRIMARY outcome

Timeframe: From the index date up to end of study (approximately 5 years post-index)

Population: All participants who were eligible as cases (CD Participants with CPAF) and controls (CD Participants without CPAF) from the ICES database were used in the analysis.

Impact of total disease burden on participants CD with and without CPAF was measured as total cost and cost by sector which included general physicians (GP), specialist, all physician OHIP, home care services, hospital admissions, dialysis, cancer, and radiation, emergency department (ED), Ontario drug benefit (ODB), hospital outpatient clinics, same day surgery (SDS). Index date was defined as the date the first time the participant meets the case definition i.e. diagnosis of CD with CPAF in the index period.

Outcome measures

Outcome measures
Measure
CD Participants With CPAF - TOH
n=1902 Participants
Participants diagnosed with CPAF from TOH were observed retrospectively in this arm group for the index period (April 1, 2007 to March 31, 2013).
CD Participants With CPAF (ICES Database)
n=581 Participants
Participants with CD and CPAF from ICES database who met the case definition were observed retrospectively in this arm group for the index period (April 1, 2007 to March 31, 2013).
Advanced Intervention
Participants with CD and CPAF received 2 x EUA ± seton and single EUA ± seton, followed by an advanced intervention or diversion procedure. The participants who did not receive EUA ± seton received advanced intervention or diversion as their 1st line of treatment in this group and were observed retrospectively in this arm group for the index period (April 1, 2007 to March 31, 2013).
Objective 2: Mean Costs for Crohn's Disease Participants With and Without CPAF in ICES Database CPAF
Total Cost
32781.12 canadian dollars
Standard Deviation 52124.77
62375.54 canadian dollars
Standard Deviation 70332.9
Objective 2: Mean Costs for Crohn's Disease Participants With and Without CPAF in ICES Database CPAF
Total Cost (Without ODB)
22866.85 canadian dollars
Standard Deviation 37256.27
36486.07 canadian dollars
Standard Deviation 42218.43
Objective 2: Mean Costs for Crohn's Disease Participants With and Without CPAF in ICES Database CPAF
Cost by Sector: General Physicians (GP)
1192.63 canadian dollars
Standard Deviation 2936.3
1275.58 canadian dollars
Standard Deviation 1974.01
Objective 2: Mean Costs for Crohn's Disease Participants With and Without CPAF in ICES Database CPAF
Cost by Sector: Specialist
5978.09 canadian dollars
Standard Deviation 5317.74
8075.60 canadian dollars
Standard Deviation 5777.89
Objective 2: Mean Costs for Crohn's Disease Participants With and Without CPAF in ICES Database CPAF
Cost by Sector: All physician OHIP
8029.55 canadian dollars
Standard Deviation 6818.29
10368.04 canadian dollars
Standard Deviation 6969.59
Objective 2: Mean Costs for Crohn's Disease Participants With and Without CPAF in ICES Database CPAF
Cost by Sector: Home Care Services
900.90 canadian dollars
Standard Deviation 14925.27
4142.01 canadian dollars
Standard Deviation 12246.05
Objective 2: Mean Costs for Crohn's Disease Participants With and Without CPAF in ICES Database CPAF
Cost by Sector: Hospital Admissions
7586.89 canadian dollars
Standard Deviation 23760.92
11079.55 canadian dollars
Standard Deviation 24994.66
Objective 2: Mean Costs for Crohn's Disease Participants With and Without CPAF in ICES Database CPAF
Cost by Sector: Dialysis, Cancer, and Radiation
64.61 canadian dollars
Standard Deviation 949.45
275.93 canadian dollars
Standard Deviation 4181.82
Objective 2: Mean Costs for Crohn's Disease Participants With and Without CPAF in ICES Database CPAF
Cost by Sector: Non-hospital Based Residential Care
182.73 canadian dollars
Standard Deviation 2797.46
217.79 canadian dollars
Standard Deviation 2781.88
Objective 2: Mean Costs for Crohn's Disease Participants With and Without CPAF in ICES Database CPAF
Cost by Sector: Emergency Department (ED)
1421.81 canadian dollars
Standard Deviation 2167.73
1807.10 canadian dollars
Standard Deviation 2658.28
Objective 2: Mean Costs for Crohn's Disease Participants With and Without CPAF in ICES Database CPAF
Cost by Sector: ODB
9917.46 canadian dollars
Standard Deviation 32562.86
25889.50 canadian dollars
Standard Deviation 52074.97
Objective 2: Mean Costs for Crohn's Disease Participants With and Without CPAF in ICES Database CPAF
Cost by Sector: Hospital Outpatient Clinics
3177.37 canadian dollars
Standard Deviation 3632.82
5660.54 canadian dollars
Standard Deviation 5234.69
Objective 2: Mean Costs for Crohn's Disease Participants With and Without CPAF in ICES Database CPAF
Cost by Sector: Same Day Surgery (SDS)
1500.39 canadian dollars
Standard Deviation 1504.51
2935.31 canadian dollars
Standard Deviation 2270.25

PRIMARY outcome

Timeframe: From the index date up to end of study (approximately 5 years post-index)

Population: All participants who were eligible as cases (CD Participants with CPAF) and controls (CD Participants without CPAF) from the ICES database were included in the analysis.

Healthcare Resource Utilization was based on three procedures which included the number of ED visits, number of hospitalizations and number of outpatient visits. Index date was defined as the date the first time the participant meets the case definition i.e. diagnosis of CD with CPAF in the index period.

Outcome measures

Outcome measures
Measure
CD Participants With CPAF - TOH
n=1902 Participants
Participants diagnosed with CPAF from TOH were observed retrospectively in this arm group for the index period (April 1, 2007 to March 31, 2013).
CD Participants With CPAF (ICES Database)
n=581 Participants
Participants with CD and CPAF from ICES database who met the case definition were observed retrospectively in this arm group for the index period (April 1, 2007 to March 31, 2013).
Advanced Intervention
Participants with CD and CPAF received 2 x EUA ± seton and single EUA ± seton, followed by an advanced intervention or diversion procedure. The participants who did not receive EUA ± seton received advanced intervention or diversion as their 1st line of treatment in this group and were observed retrospectively in this arm group for the index period (April 1, 2007 to March 31, 2013).
Objective 2: Number of Visits for Healthcare Resource Utilization for Crohn's Disease Participants With and Without CPAF in ICES Database
Number of Hospitalizations
0.95 visits
Standard Deviation 1.74
1.38 visits
Standard Deviation 2.00
Objective 2: Number of Visits for Healthcare Resource Utilization for Crohn's Disease Participants With and Without CPAF in ICES Database
Number of ED Visits
4.26 visits
Standard Deviation 6.28
5.57 visits
Standard Deviation 8.09
Objective 2: Number of Visits for Healthcare Resource Utilization for Crohn's Disease Participants With and Without CPAF in ICES Database
Number of Outpatient Visits
8.57 visits
Standard Deviation 9.81
15.18 visits
Standard Deviation 14.07

PRIMARY outcome

Timeframe: From the index date up to 5 years post-index

Population: All participants who were eligible as cases (CD Participants with CPAF) CPAF from the ICES database were included in the analysis.

Impact of total disease burden on participants CD with CPAF was based on three procedures which included total cost, total cost (without ODB) and cost by sector i.e. general physicians (GP), specialist, all physician OHIP, home care services, hospital admissions, Dialysis, Cancer, and Radiation, non-hospital based residential care, emergency department (ED), Ontario drug benefit (ODB), hospital outpatient clinics, same day surgery (SDS). Index date was defined as the date the first time the participant meets the case definition i.e. diagnosis of CD with CPAF in the index period. Participants with CD and CPAF were categorized into pre-defined treatment pathways and results are reported in three arms: No Intervention, EUA ± Seton and Advanced Intervention.

Outcome measures

Outcome measures
Measure
CD Participants With CPAF - TOH
n=237 Participants
Participants diagnosed with CPAF from TOH were observed retrospectively in this arm group for the index period (April 1, 2007 to March 31, 2013).
CD Participants With CPAF (ICES Database)
n=307 Participants
Participants with CD and CPAF from ICES database who met the case definition were observed retrospectively in this arm group for the index period (April 1, 2007 to March 31, 2013).
Advanced Intervention
n=37 Participants
Participants with CD and CPAF received 2 x EUA ± seton and single EUA ± seton, followed by an advanced intervention or diversion procedure. The participants who did not receive EUA ± seton received advanced intervention or diversion as their 1st line of treatment in this group and were observed retrospectively in this arm group for the index period (April 1, 2007 to March 31, 2013).
Objective 3: Mean Costs Based on Three Procedures for Crohn's Disease Participants With CPAF by Sector in ICES Database
Cost by Sector: Hospital Outpatient Clinics
4482.35 canadian dollars
Standard Deviation 4128.71
6202.11 canadian dollars
Standard Deviation 5617.27
8713.70 canadian dollars
Standard Deviation 6348.41
Objective 3: Mean Costs Based on Three Procedures for Crohn's Disease Participants With CPAF by Sector in ICES Database
Cost by Sector: SDS
2007.24 canadian dollars
Standard Deviation 2090.86
3515.43 canadian dollars
Standard Deviation 2132.19
4066.57 canadian dollars
Standard Deviation 2424.82
Objective 3: Mean Costs Based on Three Procedures for Crohn's Disease Participants With CPAF by Sector in ICES Database
Total Cost
45982.45 canadian dollars
Standard Deviation 51581.52
65430.16 canadian dollars
Standard Deviation 68268.35
142034.86 canadian dollars
Standard Deviation 119455.5
Objective 3: Mean Costs Based on Three Procedures for Crohn's Disease Participants With CPAF by Sector in ICES Database
Total Cost (Without ODB)
26799.65 canadian dollars
Standard Deviation 26777.44
36992.93 canadian dollars
Standard Deviation 33981.36
94326 canadian dollars
Standard Deviation 100709.22
Objective 3: Mean Costs Based on Three Procedures for Crohn's Disease Participants With CPAF by Sector in ICES Database
Cost by Sector: GP
1144.88 canadian dollars
Standard Deviation 1762.59
1218.24 canadian dollars
Standard Deviation 1583.95
2588.51 canadian dollars
Standard Deviation 4379.07
Objective 3: Mean Costs Based on Three Procedures for Crohn's Disease Participants With CPAF by Sector in ICES Database
Cost by Sector: Specialist
7128.15 canadian dollars
Standard Deviation 5772.59
8019.46 canadian dollars
Standard Deviation 4884.16
14610.30 canadian dollars
Standard Deviation 8173.77
Objective 3: Mean Costs Based on Three Procedures for Crohn's Disease Participants With CPAF by Sector in ICES Database
Cost by Sector: All physician OHIP
9293.98 canadian dollars
Standard Deviation 6771.63
10240.95 canadian dollars
Standard Deviation 5951.3
18302.27 canadian dollars
Standard Deviation 10416.85
Objective 3: Mean Costs Based on Three Procedures for Crohn's Disease Participants With CPAF by Sector in ICES Database
Cost by Sector: Home Care Services
1231.69 canadian dollars
Standard Deviation 3596.56
5217.44 canadian dollars
Standard Deviation 14078.41
13860.7 canadian dollars
Standard Deviation 21997.79
Objective 3: Mean Costs Based on Three Procedures for Crohn's Disease Participants With CPAF by Sector in ICES Database
Cost by Sector: Hospital Admissions
7615.50 canadian dollars
Standard Deviation 14938.04
9623.01 canadian dollars
Standard Deviation 18429.69
45353.59 canadian dollars
Standard Deviation 66413.97
Objective 3: Mean Costs Based on Three Procedures for Crohn's Disease Participants With CPAF by Sector in ICES Database
Cost by Sector: Dialysis, Cancer, and Radiation
212.03 canadian dollars
Standard Deviation 2312.88
350.46 canadian dollars
Standard Deviation 5383.99
66.78 canadian dollars
Standard Deviation 406.23
Objective 3: Mean Costs Based on Three Procedures for Crohn's Disease Participants With CPAF by Sector in ICES Database
Cost by Sector: Non-Hospital Based Residential Care
293.11 canadian dollars
Standard Deviation 3402.11
185.89 canadian dollars
Standard Deviation 2393.87
0.00 canadian dollars
Standard Deviation 0.00
Objective 3: Mean Costs Based on Three Procedures for Crohn's Disease Participants With CPAF by Sector in ICES Database
Cost by Sector: Emergency department (ED)
1664.22 canadian dollars
Standard Deviation 2355.68
1657.65 canadian dollars
Standard Deviation 1966.21
3962.38 canadian dollars
Standard Deviation 6285.67
Objective 3: Mean Costs Based on Three Procedures for Crohn's Disease Participants With CPAF by Sector in ICES Database
Cost by Sector: ODB
19182.85 canadian dollars
Standard Deviation 42673.84
28437.24 canadian dollars
Standard Deviation 55455.37
47708.86 canadian dollars
Standard Deviation 69074.61

PRIMARY outcome

Timeframe: From the index date up to 5 years post-index

Population: All participants who were eligible as cases (CD Participants with CPAF) CPAF from the ICES database were included in the analysis.

Healthcare Resource Utilization was based on three procedures which included the number of ED visits, number of hospitalizations and number of outpatient visits. Index date was defined as the date the first time the participant meets the case definition i.e. diagnosis of CD with CPAF in the index period. Participants with CD and CPAF were categorized into pre-defined treatment pathways and results are reported in three arms: No Intervention, EUA ± Seton and Advanced Intervention.

Outcome measures

Outcome measures
Measure
CD Participants With CPAF - TOH
n=237 Participants
Participants diagnosed with CPAF from TOH were observed retrospectively in this arm group for the index period (April 1, 2007 to March 31, 2013).
CD Participants With CPAF (ICES Database)
n=307 Participants
Participants with CD and CPAF from ICES database who met the case definition were observed retrospectively in this arm group for the index period (April 1, 2007 to March 31, 2013).
Advanced Intervention
n=37 Participants
Participants with CD and CPAF received 2 x EUA ± seton and single EUA ± seton, followed by an advanced intervention or diversion procedure. The participants who did not receive EUA ± seton received advanced intervention or diversion as their 1st line of treatment in this group and were observed retrospectively in this arm group for the index period (April 1, 2007 to March 31, 2013).
Objective 3: Number of Visits for Healthcare Resource Utilization Based on Three Procedures for Crohn's Disease Participants With CPAF
Number of ED Visits
5.29 visits
Standard Deviation 7.74
5.11 visits
Standard Deviation 5.79
11.22 visits
Standard Deviation 18.46
Objective 3: Number of Visits for Healthcare Resource Utilization Based on Three Procedures for Crohn's Disease Participants With CPAF
Number of Hospitalizations
1.06 visits
Standard Deviation 1.54
1.37 visits
Standard Deviation 1.84
3.57 visits
Standard Deviation 3.79
Objective 3: Number of Visits for Healthcare Resource Utilization Based on Three Procedures for Crohn's Disease Participants With CPAF
Number of Outpatient Visits
12.11 visits
Standard Deviation 11.31
16.57 visits
Standard Deviation 15.04
23.24 visits
Standard Deviation 16.82

Adverse Events

CD Participants With CPAF - The Ottawa Hospital (TOH)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

CD Participants Without CPAF (ICES Database)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

CD Participants With CPAF (ICES Database)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Medical Director

Takeda

Phone: +1-877-825-3327

Results disclosure agreements

  • Principal investigator is a sponsor employee The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
  • Publication restrictions are in place

Restriction type: OTHER